US President Trump on Thursday night is planning to announce the launch of TrumpRx, the website that he and his aides have touted for months as a platform aimed at lowering prescription drug prices, STAT News reports

• : A spokesperson for Goodrx, which provides discounted drug coupons on its website, told STAT that it was a “key integration partner” for Pharmaceutical companies offering discounted prices on TrumpRx, meaning drugmakers will partner with Goodrx to Host their Self-pay prices and Goodrx will integrate that pricing onto the TrumpRx platform.

The announcement of TrumpRx as a platform to lower prescription drug prices might indicate a shift in healthcare policy that could impact the pharmaceutical sector. This could affect equities related to healthcare and pharmaceuticals, and potentially influence sentiment in broader markets, as such initiatives typically garner political attention and could have regulatory implications. Keep an eye on how this development might shape market expectations around healthcare costs and stock performances in that space.